SSHRC Postdoctoral Fellowships are expected to respond to the objectives of the Talent program.

These fellowships support the most promising Canadian new scholars in the social sciences and humanities, and assist them in establishing a research base at an important time in their research careers.

The purpose of these fellowships is to provide stipendiary support to recent PhD graduates who are:

• undertaking original research;
• publishing research findings;
• developing and expanding personal research networks;
• broadening their teaching experience;
• preparing for research-intensive careers within and beyond academia; and
• preparing to become competitive in national research grant competitions.

SSHRC Postdoctoral Fellowship awards are tenable at Canadian or foreign universities and research institutions.

SSHRC welcomes applications involving Indigenous research, as well as those involving research-creation.

The HFSP fellowship program supports proposals for frontier, potentially transformative research in the life sciences. Applications for high-risk projects are particularly encouraged. The projects should be interdisciplinary in nature and should challenge existing paradigms by using novel approaches and techniques. Scientifically, they should address an important problem or a barrier to progress in the field.

HFSP postdoctoral fellowships encourage early career scientists to broaden their research skills by moving into new areas of study while working in a new country.

AMS Healthcare strives to improve the healthcare of all Canadians by innovating education and practice, championing the history of medicine and healthcare, supporting leadership development, and advancing research in the health humanities. In recent years, AMS Healthcare has provided funding for activities that address two key factors of the health care system: Compassionate care; and, artificial intelligence and digital health solutions. AMS Healthcare’s Compassionate Care in a Technological World strategic priority focusses on promoting the integration of digital technology/artificial intelligence (DT/AI) and compassionate care in the delivery of health care services, education of health professionals as well as facilitating the leadership needed to realize the promise of technology. For this competition, AMS Healthcare will also fund Fellowships in DT/AI, healthcare equity and compassionate care.

Click here to learn more about Compassionate Care in a Technological World.

AMS Healthcare is offering one-year fellowships of up to $75,000 to early and mid-career academic researchers and regulated health care professionals to study and develop expertise/competence in the impact of DT/AI on compassionate care. Those interested can click on the links below to access more information about the program and application details.

LOI submission deadline is 5:00 pm (eastern time) on Monday, July 27, 2020

$25,000 to support full-time doctoral students in the humanities or social sciences complete their dissertation on a history of medicine/healthcare topic.

AMS Healthcare strives to improve the healthcare of all Canadians by innovating education and practice, championing the history of medicine and healthcare, supporting leadership development, and advancing research in the health humanities. In recent years, AMS Healthcare has provided funding for activities that address two key factors of the health care system: Compassionate care; and, artificial intelligence and digital health solutions. AMS Healthcare’s Compassionate Care in a Technological World strategic priority focusses on promoting the integration of digital technology/artificial intelligence (DT/AI) and compassionate care in the delivery of health care services, education of health professionals as well as facilitating the leadership needed to realize the promise of technology.

Click here to learn more about Compassionate Care in a Technological World.

AMS Healthcare is offering grants of up to $20,000 to early and mid-career academic researchers and regulated health care professionals to support research, knowledge translation and spread and scale activities related to the impact of DT/AI on compassionate care. Those interested can click on the links below to access more information about the program and application details.

Full application submission deadline is 5:00 pm (eastern time) on Wednesday, September 16, 2020

The applicant must provide a justification. It must show how the proposed research aligns with the priority areas of the strategy. 

The granting agencies recognize that some research proposals may overlap agency mandates. Further, they recognize that some research may require an interdisciplinary approach. As such, the agencies are collaborating to ensure that areas of research that cross agency boundaries are eligible for support.

Applicants should consult the guidelines of each agency to select the one best suited to consider their application.

For more information on how to apply and details on application deadlines please refer to the relevant scholarship details once they become available:

• SSHRC postdoctoral fellowship application instructions
  (Competition Now Open, Deadline: September 16th, 8pm EST)

Six positions are available at IDRC's head office in Ottawa, Canada.

This call is open to:

Canadians or permanent residents of Canada who are enrolled in a master’s or a doctoral degree at a recognized university OR have completed (within the last three years) a master's or doctoral degree at a recognized university.

Citizens of a developing country who are enrolled in a master’s or a doctoral degree at a Canadian university OR have completed (within the last three years) a master's or doctoral degree at a recognized university. In either case, applicants must already have a work permit valid for full-time work (37.5 hours per week) in Canada until December 31, 2021 prior to applying.

Please note: the expectation of receiving a post-graduation work permit is not sufficient.

Additional eligibility requirements

• The proposed research must focus on one or more developing countries.
• These awards may be part of an academic requirement.
• The specific eligibility criteria of each research theme must be satisfied.

Please note: Successful award recipients cannot receive any other Canadian government scholarship, award, subsidy, bursary, or honorarium, or hold any federal government contract in support of a research/work project for the duration of the award. This includes any other IDRC award and any award managed by another institution but supported in whole or in part by IDRC, such as the Queen Elizabeth Advanced Scholars program.

The specific objectives of this funding opportunity are:

1. How demographic change is altering the implicit contract between generations.
2. How policy can ensure that change results in a reduction, rather than an increase, in inequality.

The FY20 Defense Appropriations Act provides funding to the Department of Defense Pancreatic Cancer Research Program (PCARP) to support a collaborative pancreatic cancer research paradigm that reduces the burden of pancreatic cancer.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY20 PCARP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website. 

Applications submitted to the FY20 PCARP must address one or more of the following Focus Areas:

• Understanding precursors, origins, and early progression of pancreatic cancer
• Understanding the events that promote pancreatic cancer metastasis 
• Understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
• Integration of biologic and imaging biomarkers to drive more precise and earlier detection and prognosis
• Defining viable tumor burden
• Supportive care and patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
• New drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance (for correlative studies only)
• Development of pharmacological, immunological, or genetic interception approaches

https://cdmrp.army.mil/funding/pcarp

Idea Development Award – Preproposal due August 25, 2020

Investigators at or above the level of Assistant Professor (or equivalent)

or

Early-Career Investigator Partnering Principal Investigator (PI) Option: Investigators at or above the level of Assistant Professor (or equivalent) may collaborate on a single application with a young investigator that meets the following criteria at the application submission deadline date:

• Have completed at least 3 years of postdoctoral training or medical residency program
• Is no more than 7 years from the receipt of a terminal degree
• Can commit at least 50% protected time for the project
• Preproposal is required; application submission is by invitation only.
• Supports new ideas that represent innovative, high-risk/high-gain approaches to pancreatic cancer research and have the potential to make an important contribution to one or more of the FY20 PCARP Focus Areas.
• Emphasis is equally placed on Innovation and Impact.
• Preliminary data are encouraged, but not required.
• Clinical trials are not allowed.
• Must address at least one of the FY20 PCARP Focus Areas.

Established Single PI Option:

• Maximum funding of $500,000 for direct costs (plus indirect costs)
• Maximum period of performance is 3 years

Early-Career Investigator Partnering PI Option:

• Maximum funding of $650,000 for direct costs (plus indirect costs)
• Maximum period of performance is 3 years

Translational Research Partnership Award – Preproposal due August 25, 2020

PIs must be at or above the level of Assistant Professor or equivalent.

Clinicians must be an M.D., M.D./Ph.D., or equivalent with clinical duties and/or responsibilities.

• Preproposal is required; application submission is by invitation only.
• Supports partnerships between clinicians and laboratory scientists that accelerate ideas in pancreatic cancer into clinical applications.
• Multi-institutional and multi-discipline partnerships are strongly encouraged. 
• Must address at least one of the FY20 PCARP Focus Areas.
• Supports translational correlative studies.
• Preliminary data required.
• Retrospective tissue analysis, correlative studies, or small pilot clinical studies are permitted.
• Maximum funding of $750,000 for direct costs (plus indirect costs)
• Maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PCARP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org